Preoperative beta blockers may give survival boost
Preoperative beta blockers may give survival boost
A large observational analysis associates preoperative beta-blocker therapy with a small but consistent survival benefit for patients undergoing coronary artery bypass graft surgery (CABG), according to research published in the May 1 issue of the Journal of the American Medical Association. Among patients with a left ventricular ejection fraction of less than 30%, however, preoperative beta-blocker therapy was associated with a trend toward a higher mortality rate.
The research used the Society of Thoracic Surgeons National Adult Cardiac Surgery Database (NCD) to assess beta-blocker use and outcomes among 629,877 patients undergoing CABG between 1996 and 1999 at 497 U.S. and Canadian sites. Patients who received beta-blockers had a lower 30-day mortality rate (2.8%) than those who did not (3.4%).
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.